You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
通化東寶(600867.SH):精蛋白人胰島素混合注射液(30R)獲得境外上市許可
格隆匯 03-20 15:35

格隆匯3月20日丨通化東寶(600867.SH)公佈,公司於近日收到烏茲別克斯坦共和國衞生部核准簽發的公司產品精蛋白人胰島素混合注射液(30R)的上市許可。公司精蛋白人胰島素混合注射液(30R),適用於1型或2型糖尿病。該產品是雙時相胰島素製劑,含有30%可溶性的人胰島素和70%精蛋白鋅人胰島素混懸液。可溶性胰島素起效快,能快速降低餐後血糖,精蛋白鋅人胰島素作用時間長,可提供基礎胰島素,控制空腹血糖。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account